PH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: Concept and recent advances

Nanomedicine

Volumn 9, Issue 3, 2014, Pages 487-499

  Meng, Fenghua ^a   Zhong, Yinan ^a   Cheng, Ru ^a   Deng, Chao ^a   Zhong, Zhiyuan ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Cancer chemotherapy; Cancer stem cells; Controlled release; Doxorubicin; Multidrug resistance; PH sensitive; Polymeric nanoparticles

Indexed keywords

DOXORUBICIN; GOLD NANOPARTICLE; HYDRAZONE DERIVATIVE; NANOPARTICLE; POLYAMINE; POLYMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ANTINEOPLASTIC ANTIBIOTIC; DELAYED RELEASE FORMULATION;

CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; ENDOSOME; HUMAN; LYSOSOME; MICELLE; NONHUMAN; PH; PRIORITY JOURNAL; REVIEW; TUMOR CELL; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; METABOLISM; NEOPLASMS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; NEOPLASMS; POLYMERS;

EID: 84898929476     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.212     Document Type: Review

References (75)

1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007).
2. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771-782 (2008).
3. Haag R, Kratz F. Polymer therapeutics: concepts and applications. Angew. Chem. Int. Ed. 45(8), 1198-1215 (2006).
4. Seymour LW, Ferry DR, Kerr DJ et al. Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. Int. J. Oncol. 34(6), 1629-1636 (2009).
5. Seymour LW, Ferry DR, Anderson D et al. Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin. J. Clin. Oncol. 20(6), 1668-1676 (2002).
6. Matsumura Y, Hamaguchi T, Ura T et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelleencapsulated doxorubicin. Br. J. Cancer 91, 1775-1781 (2004).
7. Valle JW, Armstrong A, Newman C et al. A Phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest. New Drugs 29(5), 1029-1037 (2011).
8. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7(11), 653-664 (2010).
9. Lammers T, Kiessling F, Hennink WE, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. 161, 175-187 (2012).
10. Deng C, Jiang YJ, Cheng R, Meng FH, Zhong ZY. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects. Nano Today 7(5), 467-480 (2012).
11. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66(13), 6699-6707 (2006).
12. Grabe M, Oster G. Regulation of organelle acidity. J. Gen. Physiol. 117(4), 329-343 (2001).
13. Dong D-W, Tong S-W, Qi X-R. Comparative studies of polyethylenimine- doxorubicin conjugates with pH-sensitive and pH-insensitive linkers. J. Biomed. Mat. Res. A 101A(5), 1336-1344 (2013).
14. Kim D, Gao ZG, Lee ES, Bae YH. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol. Pharm. 6(5), 1353-1362 (2009).
15. Meng FH, Cheng R, Deng C, Zhong ZY. Intracellular drug release nanosystems. Mater. Today 15(10), 436-442 (2012).
16. Johnson RP, Jeong Y-I, Choi E et al. Biocompatible poly(2- hydroxyethyl methacrylate)-b-poly(L-histidine) hybrid materials for pH-sensitive intracellular anticancer drug delivery. Adv. Func. Mater. 22(5), 1058-1068 (2012).
17. Liu R, Li D, He B et al. Anti-tumor drug delivery of pHsensitive poly(ethylene glycol)-poly(L-histidine-)-poly(Llactide) nanoparticles. 152(1), 49-56 (2011).
18. Qiu L, Zheng C, Zhao Q. Mechanisms of drug resistance reversal in Dox-resistant MCF-7 cells by pH-responsive amphiphilic polyphosphazene containing diisopropylamino side groups. Mol. Pharm. 9(5), 1109-1117 (2012).
19. Huo M, Zou A, Yao C et al. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG- deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles. Biomaterials 33(27), 6393-6407 (2012).
20. Brinkhuis RE, Visser TR, Rutjes F, van Hest JC. Shedding the hydrophilic mantle of polymersomes. Polym. Chem. 2(3), 550-552 (2011).
21. Ding C, Gu J, Qu X, Yang Z. Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker. Bioconjugate Chem. 20(6), 1163-1170 (2009).
22. Jin Y, Song L, Su Y et al. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers. Biomacromolecules 12(10), 3460-3468 (2011).
23. Sun HL, Guo BN, Cheng R, Meng FH, Liu HY, Zhong ZY. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 30(31), 6358-6366 (2009).
24. Wang W, Sun HL, Meng FH, Ma SB, Liu HY, Zhong ZY. Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction sensitive shell-shedding. Soft Matter 8(14), 3949-3956 (2012).
25. Wang XY, Sun HL, Meng FH, Cheng R, Deng C, Zhong ZY. Galactose-decorated reduction-sensitive degradable chimaeric polymersomes as a multifunctional nanocarrier to efficiently chaperone apoptotic proteins into hepatoma cells. Biomacromolecules 14(8), 2873-2882 (2013).
26. Wu LL, Zou Y, Deng C, Cheng R, Meng FH, Zhong ZY. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. Biomaterials 34(21), 5262-5272 (2013).
27. Gillies ER, Fréchet JM. pH-responsive copolymer assemblies for controlled release of doxorubicin. Bioconjugate Chem. 16(2), 361-368 (2005).
28. Chen W, Meng FH, Cheng R, Zhong ZY. pH-sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J. Control. Release 142(1), 40-46 (2010).
29. Chen W, Meng FH, Li F, Ji S-J, Zhong ZY. pH-responsive biodegradable micelles based on acid-labile polycarbonate hydrophobe: synthesis and triggered drug release. Biomacromolecules 10(7), 1727-1735 (2009).
30. Du YF, Chen W, Zheng M, Meng FH, Zhong ZY. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride. Biomaterials 33, 7291-7299 (2012).
31. Hu X, Jing X. Biodegradable amphiphilic polymer-drug conjugate micelles. Expert. Opin. Drug Deliv. 6(10), 1079-1090 (2009).
32. Zhou L, Cheng R, Tao HQ et al. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice. Biomacromolecules 12(5), 1460-1467 (2011).
33. Calderon M, Welker P, Licha K et al. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell. 151(3), 295-301 (2011).
34. Hussain AF, Krueger HR, Kampmeier F et al. Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR(+) cancer cell growth. Biomacromolecules 14(8), 2510-2520 (2013).
35. Yoo HS, Lee EA, Park TG. Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J. Control. Release 82(1), 17-27 (2002).
36. Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 42(38), 4640-4643 (2003).
37. Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjugate Chem. 18(4), 1131-1139 (2007).
38. Hruby M, Konak C, Ulbrich K. Polymeric micellar pHsensitive drug delivery system for doxorubicin. J. Control. Release 103(1), 137-148 (2005).
39. Vetvicka D, Hruby M, Hovorka O et al. Biological evaluation of polymeric micelles with covalently bound doxorubicin. Bioconjugate Chem. 20(11), 2090-2097 (2009).
40. Hu X, Liu S, Huang Y, Chen X, Jing X. Biodegradable block copolymer-doxorubicin conjugates via different linkages: preparation, characterization, and in vitro evaluation. Biomacromolecules 11(8), 2094-2102 (2010).
41. Hu X, Wang R, Yue J, Liu S, Xie Z, Jing X. Targeting and anti-tumor effect of folic acid-labeled polymer-doxorubicin conjugates with pH-sensitive hydrazone linker. J. Mater. Chem. 22(26), 13303-13310 (2012).
42. Yang X, Grailer JJ, Rowland IJ et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano 4(11), 6805-6817 (2010).
43. She W, Luo K, Zhang C et al. The potential of selfassembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy. Biomaterials 34(5), 1613-1623 (2013).
44. Zhan FX, Chen W, Wang ZJ et al. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Biomacromolecules 12(10), 3612-3620 (2011).
45. Kratz F. INNO-206 (DOXO-EMCH), an albumin-binding prodrug of doxorubicin under development for Phase II studies. Curr. Bioactive Compounds 7(1), 33-38 (2011).
46. Graeser R, Esser N, Unger H et al. INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared with doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model. Invest. New Drugs 28(1), 14-19 (2010).
47. Oishi M, Hayashi H, Iijima M, Nagasaki Y. Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive PEGylated nanogels. J. Mater. Chem. 17(35), 3720-3725 (2007).
48. Kamimura M, Furukawa T, Akiyama S-I, Nagasaki Y. Enhanced intracellular drug delivery of pH-sensitive doxorubicin/poly(ethylene glycol)-block-poly(4- vinylbenzylphosphonate) nanoparticles in multi-drug resistant human epidermoid KB carcinoma cells. Biomater. Sci. 1(4), 361-367 (2013).
49. Wang F, Wang Y-C, Dou S, Xiong M-H, Sun T-M, Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 5(5), 3679-3692 (2011).
50. Xiong X-B, Lavasanifar A. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 5(6), 5202-5213 (2011).
51. Gullotti E, Yeo Y. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol. Pharm. 6(4), 1041-1051 (2009).
52. Lee ES, Gao Z, Bae YH. Recent progress in tumor pH targeting nanotechnology. J. Control. Release 132(3), 164-170 (2008).
53. Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148(2), 135-146 (2010).
54. Lee ES, Na K, Bae YH. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control. Release 103(2), 405-418 (2005).
55. Ko J, Park K, Kim Y-S et al. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (beta-amino ester) block copolymer micelles for cancer therapy. J. Control. Release 123(2), 109-115 (2007).
56. Wu XL, Kim JH, Koo H et al. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjugate Chem. 21(2), 208-213 (2010).
57. Oh KT, Oh YT, Oh N-M, Kim K, Lee DH, Lee ES. A smart flower-like polymeric micelle for pH-triggered anticancer drug release. Int. J. Pharm. 375(1-2), 163-169 (2009).
58. Du J-Z, Du X-J, Mao C-Q, Wang J. Tailor-made dual pHsensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J. Am. Chem. Soc. 133(44), 17560-17563 (2011).
59. Du J-Z, Sun T-M, Song W-J, Wu J, Wang J. A tumoracidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew. Chem. Int. Ed. 49(21), 3621-3626 (2010).
60. Hu F-Q, Zhang Y-Y, You J, Yuan H, Du Y-Z. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Mol. Pharm. 9(9), 2469-2478 (2012).
61. Lee ES, Gao Z, Kim D, Park K, Kwon IC, Bae YH. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J. Control. Release 129(3), 228-236 (2008).
62. Sethuraman VA, Bae YH. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J. Control. Release 118(2), 216-224 (2007).
63. Jin E, Zhang B, Sun X et al. Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery. J. Am. Chem. Soc. 135(2), 933-940 (2013).
64. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 5(2), 325-329 (2005).
65. Yuan Z, Que Z, Cheng S, Zhuo R, Li F. pH-triggered blooming of nano-flowers' for tumor intracellular drug delivery. Chem. Commun. 48(65), 8129-8131 (2012).
66. Bae YH, Yin H. Stability issues of polymeric micelles. J. Control. Release 131(1), 2-4 (2008).
67. Owen SC, Chan DPY, Shoichet MS. Polymeric micelle stability. Nano Today 7(1), 53-65 (2012).
68. Wu YL, Chen W, Meng FH et al. Core-crosslinked pH-sensitive degradable micelles: a promising approach to resolve the extracellular stability versus intracellular drug release dilemma. J. Control. Release 164(3), 338-345 (2012).
69. Lee SJ, Min KH, Lee HJ et al. Ketal cross-linked poly(ethylene glycol)-poly(amino acid)s copolymer micelles for efficient intracellular delivery of doxorubicin. Biomacromolecules 12(4), 1224-1233 (2011).
70. Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials 33(23), 5788-5797 (2012).
71. Fan J, Zeng F, Wu S, Wang X. Polymer micelle with pH-triggered hydrophobic-hydrophilic transition and de-cross-linking process in the core and its application for targeted anticancer drug delivery. Biomacromolecules 13(12), 4126-4137 (2012).
72. Dai J, Lin S, Cheng D, Zou S, Shuai X. Interlayercrosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew. Chem. Int. Ed. 50(40), 9404-9408 (2011).
73. Talelli M, Iman M, Varkouhi AK et al. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials 31(30), 7797-7804 (2010).
74. Cheng R, Meng FH, Deng C, Klok H-A, Zhong ZY. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34(14), 3647-3657 (2013).
75. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8(10), 755-768 (2008).